Correspondence 0001213900-24-073912 from Silo Pharma, Inc. (SILO)
Silo Pharma, Inc.
Date: Aug. 29, 2024 · CIK: 0001514183 · Accession: 0001213900-24-073912
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281692
Letter
Silo Pharma, Inc.
677 N. Washington Boulevard
Sarasota, FL 34236
August 29, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Silo Pharma, Inc.
Registration Statement on Form S-1
File No. 333-281692
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Silo Pharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Tuesday, September 3, 2024, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Please notify Greg Carney of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.
Very truly yours,
SILO PHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
Silo Pharma, Inc.
677 N. Washington Boulevard
Sarasota, FL 34236
August 29, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Silo Pharma, Inc.
Registration Statement on Form S-1
File No. 333-281692
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Silo Pharma, Inc. (the
“Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so
that it will become effective at 5:00 p.m., Eastern Daylight Time, on Tuesday, September 3, 2024, or as soon thereafter as possible.
In making this acceleration request, the Company acknowledges that it is aware of its responsibilities
under the Act.
Please notify Greg Carney
of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration
statement has been declared effective pursuant to this acceleration request.
Very truly yours,
SILO PHARMA, INC.
By:
/s/ Eric Weisblum
Name:
Eric Weisblum
Title:
Chief Executive Officer
cc: Greg Carney, Sheppard Mullin Richter & Hampton LLP